Telomir Pharmaceuticals | 10-Q:季度报表
Telomir Pharmaceuticals | 8-K:重大事件
Telomir Pharmaceuticals | 8-K:重大事件
Telomir Pharmaceuticals | 10-K:年度报表
Telomir Pharmaceuticals | 4:持股变动声明-股东 Bay Shore Trust
Telomir Pharmaceuticals | 8-K:重大事件
Telomir Pharmaceuticals | 424B4:募资说明书
Telomir Pharmaceuticals | 424B1:募资说明书
Telomir Pharmaceuticals | EFFECT:其他
Telomir Pharmaceuticals | 3:首次持股声明-股东 Bay Shore Trust
Telomir Pharmaceuticals | 3:首次持股声明-董事 Tuck Talhia
Telomir Pharmaceuticals | 3:首次持股声明-高管 Fuentes Nathen
Telomir Pharmaceuticals | 3:首次持股声明-董事 Jerman Michael Allen
Telomir Pharmaceuticals | 3:首次持股声明-董事 McColl Hugh III
Telomir Pharmaceuticals | 3:首次持股声明-董事 EAGLE CRAIG
Telomir Pharmaceuticals | 3:首次持股声明-高管 Nicholoudis Christos
Telomir Pharmaceuticals | 3:首次持股声明-高管 Chapman Christopher C JR
Telomir Pharmaceuticals | 3:首次持股声明-董事 Kroenig Bradley
Telomir Pharmaceuticals | CERT:其他
Telomir Pharmaceuticals | 8-A12B:证券登记/上市
暂无数据